Skip to content
Disclosery

Exome Asset Management LLC

Follow

13F filer, CIK 2011932, NEW YORK, NY

Exome Asset Management LLC reported $209,146,246 across 60 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13. Its ten largest share positions make up 44.09% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-000376

Period
2025-12-31
Reported value
$209M
Holdings
60
Top 10 weight
44.09%
New
26
Sold out
34

Largest buys vs the previous quarter

SecurityShares changeApprox. value
WVEnew+421,488$7.17M
ELVnew+17,191$6.03M
JAZZnew+26,494$4.5M
AGIOnew+136,942$3.73M
ELVNnew+222,308$3.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
PRAXreduced-43,874-$12.9M
COGTreduced-137,979-$4.9M
89BIO INCexited-273,661-$4.02M
BBIOreduced-52,364-$4.01M
APGEexited-94,400-$3.75M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001420506-26-000376, largest first. % of portfolio is the value over $202,429,044, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 59,002 shares; 2025Q3: 101,996 shares; 2025Q4: 58,122 shares 58,122$17.1M8.46%-43,874Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 621,678 shares; 2025Q2: 533,647 shares; 2025Q3: 443,547 shares; 2025Q4: 305,568 shares 305,568$10.9M5.36%-137,979Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 89,800 shares; 2024Q4: 147,800 shares; 2025Q1: 127,182 shares; 2025Q2: 98,182 shares; 2025Q3: 98,182 shares; 2025Q4: 98,182 shares 98,182$10M4.95%0Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 61,367 shares; 2025Q1: 135,616 shares; 2025Q2: 121,116 shares; 2025Q3: 131,016 shares; 2025Q4: 116,515 shares 116,515$9.22M4.55%-14,501Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,447 shares; 2024Q4: 8,247 shares; 2025Q1: 4,673 shares; 2025Q2: 4,673 shares; 2025Q3: 7,852 shares; 2025Q4: 7,852 shares 7,852$8.44M4.17%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,583 shares; 2024Q4: 65,883 shares; 2025Q1: 103,483 shares; 2025Q2: 115,817 shares; 2025Q3: 142,417 shares; 2025Q4: 124,749 shares 124,749$7.93M3.92%-17,668Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 421,488 shares 421,488$7.17M3.54%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 76,700 shares; 2025Q3: 156,072 shares; 2025Q4: 124,391 shares 124,391$6.3M3.11%-31,681Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 211,000 shares; 2024Q4: 246,700 shares; 2025Q1: 165,496 shares; 2025Q2: 155,533 shares; 2025Q3: 133,087 shares; 2025Q4: 80,723 shares 80,723$6.17M3.05%-52,364Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,191 shares 17,191$6.03M2.98%newTimeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 32,534 shares; 2025Q2: not reported; 2025Q3: 28,362 shares; 2025Q4: 28,362 shares 28,362$5.26M2.6%0Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 26,494 shares 26,494$4.5M2.22%newTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,450 shares; 2024Q4: 22,450 shares; 2025Q1: 18,650 shares; 2025Q2: 18,650 shares; 2025Q3: 18,650 shares; 2025Q4: 18,650 shares 18,650$4.27M2.11%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 158,622 shares; 2025Q4: 158,622 shares 158,622$4.03M1.99%0Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,100 shares; 2025Q3: 7,955 shares; 2025Q4: 17,628 shares 17,628$3.84M1.9%+9,673Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,645 shares; 2025Q4: 7,685 shares 7,685$3.74M1.85%+1,040Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,200 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,942 shares 136,942$3.73M1.84%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,516 shares; 2024Q4: 69,072 shares; 2025Q1: 61,656 shares; 2025Q2: 61,356 shares; 2025Q3: 61,356 shares; 2025Q4: 46,743 shares 46,743$3.71M1.83%-14,613Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,427 shares; 2024Q4: 7,427 shares; 2025Q1: 6,358 shares; 2025Q2: 6,358 shares; 2025Q3: 6,358 shares; 2025Q4: 6,358 shares 6,358$3.6M1.78%0Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,857 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 27,143 shares; 2025Q4: 31,471 shares 31,471$3.55M1.76%+4,328Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 222,308 shares 222,308$3.42M1.69%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 34,289 shares 34,289$3.42M1.69%newTimeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100,367 shares; 2024Q4: 119,467 shares; 2025Q1: not reported; 2025Q2: 98,600 shares; 2025Q3: not reported; 2025Q4: 135,849 shares 135,849$3.41M1.69%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 118,017 shares; 2025Q2: 153,278 shares; 2025Q3: 156,917 shares; 2025Q4: 89,052 shares 89,052$3.4M1.68%-67,865Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,147 shares 50,147$3.33M1.64%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 104,507 shares; 2025Q4: 49,758 shares 49,758$3.3M1.63%-54,749Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 745,305 shares; 2025Q4: 745,305 shares 745,305$3.17M1.57%0Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares; 2025Q3: 94,235 shares; 2025Q4: 91,148 shares 91,148$3.14M1.55%-3,087Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 599,900 shares; 2025Q3: not reported; 2025Q4: 401,743 shares 401,743$3.1M1.53%newTimeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,770 shares; 2025Q4: 292,250 shares 292,250$2.85M1.41%-520Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 9,000 shares; 2025Q1: 9,000 shares; 2025Q2: 9,000 shares; 2025Q3: 9,000 shares; 2025Q4: 9,000 shares 9,000$2.8M1.38%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 163,658 shares; 2025Q3: 163,658 shares; 2025Q4: 163,658 shares 163,658$2.67M1.32%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 76,750 shares 76,750$2.66M1.32%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 59,900 shares; 2024Q4: 81,473 shares; 2025Q1: 71,438 shares; 2025Q2: 124,470 shares; 2025Q3: 173,439 shares; 2025Q4: 100,046 shares 100,046$2.48M1.23%-73,393Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 165,000 shares 165,000$2.34M1.16%newTimeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,328 shares 14,328$2.29M1.13%newTimeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,900 shares; 2025Q3: 46,900 shares; 2025Q4: 68,969 shares 68,969$2.26M1.12%+22,069Timeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 648,532 shares 648,532$2.19M1.08%newTimeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 295,541 shares 295,541$2.18M1.07%newTimeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 262,625 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,060,221 shares 1,060,221$2M0.99%newTimeline
NBPNOVABRIDGE BIOSCIENCESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,439,604 shares; 2025Q4: 499,587 shares 499,587$1.99M0.98%-940,017Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,835 shares 5,835$1.93M0.95%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 758,203 shares 758,203$1.78M0.88%newTimeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,960 shares; 2025Q4: 64,845 shares 64,845$1.76M0.87%+12,885Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 468,499 shares; 2024Q4: 1,097,999 shares; 2025Q1: 1,097,999 shares; 2025Q2: 1,097,999 shares; 2025Q3: 451,699 shares; 2025Q4: 451,699 shares 451,699$1.4M0.69%0Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 600,000 shares 600,000$1.23M0.61%newTimeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,378 shares 5,378$1.21M0.6%newTimeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 27,000 shares; 2025Q3: 18,100 shares; 2025Q4: 6,084 shares 6,084$1.21M0.6%-12,016Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 289,690 shares; 2025Q2: 277,317 shares; 2025Q3: 229,962 shares; 2025Q4: 139,543 shares 139,543$1.14M0.56%-90,419Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 283,599 shares; 2025Q1: 689,137 shares; 2025Q2: 444,949 shares; 2025Q3: 98,799 shares; 2025Q4: 92,055 shares 92,055$1.04M0.51%-6,744Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,700 shares; 2024Q4: 13,100 shares; 2025Q1: 13,100 shares; 2025Q2: 13,100 shares; 2025Q3: 13,100 shares; 2025Q4: 13,100 shares 13,100$955K0.47%0Timeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,194 shares 14,194$481K0.24%newTimeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,300 shares; 2025Q1: not reported; 2025Q2: 75,484 shares; 2025Q3: 75,484 shares; 2025Q4: 75,484 shares 75,484$363K0.18%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC PUTput74,700$2.85Mnew
DISC MEDICINE INCDISC MEDICINE INC PUTput16,000$1.27Mnew
ULTRAGENYX PHARMACEUTICAL INULTRAGENYX PHARMACEUTICAL IN COMcall35,200$810Knew
ALUMIS INCALUMIS INC COMput53,200$519Knew
ALDEYRA THERAPEUTICS INCALDEYRA THERAPEUTICS INC COMcall100,000$518Knew
PRECIGEN INCPRECIGEN INC COMput100,000$418K0
SOLENO THERAPEUTICS INCSOLENO THERAPEUTICS INC PUTput7,100$328Knew

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
89BIO INC89BIO INC273,661$4.02Mshares
APGEAPOGEE THERAPEUTICS INC94,400$3.75Mshares
CVSCVS HEALTH CORP43,600$3.29Mshares
SLNOSOLENO THERAPEUTICS INC48,445$3.27Mshares
AKROAKERO THERAPEUTICS INC58,579$2.78Mshares
PPHVANECK ETF TRUST30,000$2.71Mcall
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC110,000$2.63Mcall
GERNGERON CORP1,858,354$2.55Mshares
CNTACENTESSA PHARMACEUTICALS PLC88,024$2.13Mshares
NOVO-NORDISK A SNOVO-NORDISK A S35,000$1.94Mcall
CORCENCORA INC6,000$1.88Mshares
SNDXSYNDAX PHARMACEUTICALS INC117,783$1.81Mshares
SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC2,000,000$1.76Mshares
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC2,000,000$1.63Mshares
ORICORIC PHARMACEUTICALS INC120,644$1.45Mshares
PRCTPROCEPT BIOROBOTICS CORP39,900$1.42Mshares
INSPINSPIRE MED SYS INC18,600$1.38Mshares
QUREUNIQURE NV22,090$1.29Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS178,084$1.28Mshares
AVTXAVALO THERAPEUTICS INC100,036$1.27Mshares
LIQUIDIA CORPORATIONLIQUIDIA CORPORATION53,000$1.21Mput
ARCTURUS THERAPEUTICS HLDGSARCTURUS THERAPEUTICS HLDGS50,000$922Kput
MBXMBX BIOSCIENCES INC52,402$917Kshares
MBX BIOSCIENCES INCMBX BIOSCIENCES INC50,500$884Kput
COGENT BIOSCIENCES INCCOGENT BIOSCIENCES INC45,000$646Kcall
CENTESSA PHARMACEUTICALS PLCCENTESSA PHARMACEUTICALS PLC25,000$606Kput
PRAXIS PRECISION MEDICINES IPRAXIS PRECISION MEDICINES I10,000$530Kcall
MBX BIOSCIENCES INCMBX BIOSCIENCES INC30,000$525Kcall
ACADACADIA PHARMACEUTICALS INC20,000$427Kput
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC48,100$315Kput
REPLREPLIMUNE GROUP INC73,614$308Kshares
VTYXVENTYX BIOSCIENCES INC60,600$188Kshares
IMUXIMMUNIC INC173,900$153Kshares
ATYRATYR PHARMA INC40,000$28.8Kcall

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-000376 base2026-02-13acceptance time not in the bulk data set